{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T22:12:07Z","timestamp":1791756727205,"version":"4.3.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2020Y0042"],"award-info":[{"award-number":["2020Y0042"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017543","name":"Fujian Provincial Hospital","doi-asserted-by":"publisher","award":["2021ZD02001"],"award-info":[{"award-number":["2021ZD02001"]}],"id":[{"id":"10.13039\/501100017543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.heliyon.2023.e23583","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T14:35:52Z","timestamp":1702391752000},"page":"e23583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The immune inflammation factors associated with disease severity and poor prognosis in patients with COVID-19: A retrospective cohort study"],"prefix":"10.1016","volume":"10","author":[{"given":"Yanli","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifa","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9997-5881","authenticated-orcid":false,"given":"Ruifang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbin","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongbin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5334-1656","authenticated-orcid":false,"given":"Liangyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e23583_bib1","unstructured":"WHO. Coronavirus Disease (COVID-19) Dashboard. (accessed Feb 12, 2023). https:\/\/covid19.who.int\/.."},{"issue":"10223","key":"10.1016\/j.heliyon.2023.e23583_bib2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.heliyon.2023.e23583_bib3","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"China medical treatment expert group for covid-19. Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e23583_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.668725","article-title":"Complement anaphylatoxins and inflammatory cytokines as prognostic markers for COVID-19 severity and in-hospital mortality","volume":"12","author":"Alosaimi","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23583_bib5","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1172\/JCI90962","article-title":"The role of the complement system in cancer","volume":"127","author":"Afshar-Kharghan","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e23583_bib6","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Valle Dm","year":"2020","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e23583_bib7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.pulmoe.2021.03.008","article-title":"The immune response to SARS-CoV-2 and COVID-19 immunopathology-Current perspectives","volume":"27","author":"Boechat","year":"2021","journal-title":"Pulmonology"},{"key":"10.1016\/j.heliyon.2023.e23583_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103500","article-title":"SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients","volume":"70","author":"Chen","year":"2021","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23583_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12998","article-title":"Coronavirus disease 2019 (COVID-19): an overview of the immunopathology, serological diagnosis and management","volume":"93","author":"Anka","year":"2021","journal-title":"Scand. J. Immunol."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e23583_bib10","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.4049\/jimmunol.2001327","article-title":"The inflammatory factors associated with disease severity to predict COVID-19 progression","volume":"206","author":"Huang","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.heliyon.2023.e23583_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119245","article-title":"A double edged-sword - the Complement System during SARS-CoV-2 infection","volume":"272","author":"Santiesteban-Lores","year":"2021","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e23583_bib12","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/all.14238","article-title":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China","volume":"75","author":"Hang","year":"2020","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23583_bib13","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1186\/s12879-021-06457-1","article-title":"Associations of immunological features with COVID-19 severity: a systematic review and meta-analysis","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23583_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12016-021-08908-8","article-title":"Identification of parameters representative of immune dysfunction in patients with severe and fatal COVID-19 infection: a systematic review and meta-analysis","volume":"64","author":"Qin","year":"2023","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23583_bib15","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/all.15633","article-title":"A compilation answering 50 questions on monkeypox virus and the current monkeypox outbreak","volume":"78","author":"Cabanillas","year":"2023","journal-title":"Allergy"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e23583_bib16","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/all.14364","article-title":"Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19","volume":"75","author":"Azkur","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.heliyon.2023.e23583_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101205","article-title":"Aging in COVID-19: vulnerability, immunity and intervention","volume":"65","author":"Chen","year":"2021","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23583_bib18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.14336\/AD.2022.0620","article-title":"A bibliometric analysis of aging in COVID-19","volume":"14","author":"Guo","year":"2023","journal-title":"Aging Dis."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23583_bib19","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2022.01.017","article-title":"Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease","volume":"55","author":"Vijayakumar","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.heliyon.2023.e23583_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102763","article-title":"Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients","volume":"55","author":"Liu","year":"2020","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23583_bib21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.immuni.2020.07.020","article-title":"Distinct early serological signatures track with SARS-CoV-2 survival","volume":"53","author":"Atyeo","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.heliyon.2023.e23583_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119245","article-title":"A double edged-sword - the Complement System during SARS-CoV-2 infection","volume":"272","author":"Santiesteban-Lores","year":"2021","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e23583_bib23","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.heliyon.2023.e23583_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl. Res."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23583_bib25","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/infdis\/jiaa646","article-title":"Complement activation in the disease course of coronavirus disease 2019 and its effects on clinical outcomes","volume":"223","author":"De Nooijer","year":"2021","journal-title":"J. Infect. Dis."},{"issue":"Pt A","key":"10.1016\/j.heliyon.2023.e23583_bib26","article-title":"Decreased complement C3 levels are associated with poor prognosis in patients with COVID-19: a retrospective cohort study","volume":"89","author":"Fang","year":"2020","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.heliyon.2023.e23583_bib27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-3-030-63761-3_7","article-title":"Genetic polymorphisms in the host and COVID-19 infection","volume":"1318","author":"Delanghe","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.heliyon.2023.e23583_bib28","doi-asserted-by":"crossref","unstructured":"Tan L, Wang Q, Zhang D, et al., Lymphopenia predicts disease severity of COVID-19: a descriptive and p redictive study. Signal Transduct. Targeted Ther..5(1):33. https:\/\/doi:10.1038\/s41392-020-0148-4..","DOI":"10.1038\/s41392-020-0148-4"},{"key":"10.1016\/j.heliyon.2023.e23583_bib29","first-page":"131","article-title":"Lymphopenia is associated with severe coronavirus disease","volume":"96","author":"Zhao","year":"2019","journal-title":"(COVID- 19) infections: Syst. Rev. Meta-Anal. Int. J. Infect. Dis."},{"key":"10.1016\/j.heliyon.2023.e23583_bib30","doi-asserted-by":"crossref","unstructured":"Jiang M, Guo Y, Luo Q, et al., T-Cell Subset Counts in Peripheral Blood Can Be Used as Discriminatory Biomarkers for Diagnosis and Severity Prediction of Coronavirus Disea se 2019. J. Infect. Dis..222(2):198-202. https:\/\/doi:10.1093\/infdis\/jiaa252..","DOI":"10.1093\/infdis\/jiaa252"},{"key":"10.1016\/j.heliyon.2023.e23583_bib31","doi-asserted-by":"crossref","unstructured":"Riggioni C, Comberiati P, Giovannini M, et al., A compendium answering 150 questions on COVID-19 and SARS-CoV-2. Allergy.75(10):2503-2541. https:\/\/doi:10.1111\/all.14449..","DOI":"10.1111\/all.14449"},{"key":"10.1016\/j.heliyon.2023.e23583_bib32","doi-asserted-by":"crossref","unstructured":"Huang W, Berube J, McNamara M, et al., Lymphocyte Subset Counts in COVID-19 Patients: A Meta-Analysis. Cytometry.97(8):772-776. https:\/\/doi:10.1002\/cyto.a.24172..","DOI":"10.1002\/cyto.a.24172"},{"key":"10.1016\/j.heliyon.2023.e23583_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.610300","article-title":"Different innate and adaptive immune responses to SARS-CoV-2 infection of asymptomatic, mild, and severe cases","volume":"11","author":"Carsetti","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2023.e23583_bib34","doi-asserted-by":"crossref","unstructured":"Huang I, Pranata R, Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis. J. Intensive Care.8:36. https:\/\/doi:10.1186\/s40560-020-00453-4..","DOI":"10.1186\/s40560-020-00453-4"},{"key":"10.1016\/j.heliyon.2023.e23583_bib35","doi-asserted-by":"crossref","unstructured":"Kuri-Cervantes L, Pampena MB, Meng W, et al., Comprehensive mapping of immune perturbations associated with severe C OVID-19. Sci. Immunol..5(49):eabd7114. https:\/\/doi:10.1126\/sciimmunol.abd7114..","DOI":"10.1126\/sciimmunol.abd7114"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e23583_bib36","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.cell.2021.02.010","article-title":"Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection","volume":"184","author":"Anderson","year":"2021","journal-title":"Cell"},{"issue":"5\u20136","key":"10.1016\/j.heliyon.2023.e23583_bib37","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/10428199509059636","article-title":"CD19 antigen in leukemia and lymphoma diagnosis and immunotherapy","volume":"18","author":"Scheuermann","year":"1995","journal-title":"Leuk. Lymphoma"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23583_bib38","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","article-title":"Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity","volume":"183","author":"Rydyznski","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23583_bib39","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.immuni.2020.07.026","article-title":"Acute SARS-CoV-2 infection impairs dendritic cell and T cell responses","volume":"53","author":"Zhou","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.heliyon.2023.e23583_bib40","doi-asserted-by":"crossref","unstructured":"Standiford T.J, Anti-inflammatory cytokines and cytokine antagonists. Curr. Pharmaceut. Des..6(6):633-649.https:\/\/10.2174\/1381612003400533..","DOI":"10.2174\/1381612003400533"},{"key":"10.1016\/j.heliyon.2023.e23583_bib41","doi-asserted-by":"crossref","unstructured":"Darif D, Hammi I, Kihel A, et al., The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong? Microb. Pathog..153:104799. https:\/\/10.1016\/j.micpath.2021.104799..","DOI":"10.1016\/j.micpath.2021.104799"},{"issue":"2\u20133","key":"10.1016\/j.heliyon.2023.e23583_bib42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1359-6101(00)00027-7","article-title":"The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion","volume":"12","author":"Levy","year":"2001","journal-title":"Cytokine Growth Factor Rev."},{"issue":"15","key":"10.1016\/j.heliyon.2023.e23583_bib43","doi-asserted-by":"crossref","first-page":"8479","DOI":"10.1128\/JVI.00724-14","article-title":"Interleukin-6 (IL-6) and IL-17 synergistically promote viral persistence by inhibiting cellular apoptosis and cytotoxic T cell function","volume":"88","author":"Hou","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.heliyon.2023.e23583_bib44","doi-asserted-by":"crossref","unstructured":"Bordoni V, Sacchi A, Cimini E, et al., An Inflammatory Profile Correlates With Decreased Frequency of Cytotox ic Cells in Coronavirus Disease 2019. Clin. Inf. Dis. : Off. Publ. Inf. Dis. Soc. Am..71(16):2272-2275, https:\/\/10.1093\/cid\/ciaa577..","DOI":"10.1093\/cid\/ciaa577"},{"key":"10.1016\/j.heliyon.2023.e23583_bib45","doi-asserted-by":"crossref","unstructured":"Hasanvand A, COVID-19 and the role of cytokines in this disease. Inflammopharmacology.30(3):789-798. https:\/\/10.1007\/s10787-022-00992-2..","DOI":"10.1007\/s10787-022-00992-2"},{"key":"10.1016\/j.heliyon.2023.e23583_bib46","doi-asserted-by":"crossref","unstructured":"Del Valle DM, Kim-Schulze S, Huang H-H, et al., An inflammatory cytokines signature predicts COVID-19 severity and surv ival. Nat. Med..26(10):1636-1643. https:\/\/10.1038\/s41591-020-1051-9..","DOI":"10.1038\/s41591-020-1051-9"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23583_bib47","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/22221751.2020.1770129","article-title":"Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors","volume":"9","author":"Han","year":"2020","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.heliyon.2023.e23583_bib48","doi-asserted-by":"crossref","unstructured":"Mortaz E, Tabarsi P, Varahram M, et al., The immune response and immunopathology of COVID-19. Front. Immunol..11:2037.https:\/\/10.3389\/fimmu.2020.02037..","DOI":"10.3389\/fimmu.2020.02037"},{"key":"10.1016\/j.heliyon.2023.e23583_bib49","volume":"284","author":"Kunnumakkara","year":"2021","journal-title":"COVID-19, Cytokines, Inflamm., Spices: How are they related?Life sciences"},{"key":"10.1016\/j.heliyon.2023.e23583_bib50","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev-med-042220-012417","article-title":"COVID-19: inflammatory profile","volume":"73","author":"Wang","year":"2022","journal-title":"Annu. Rev. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23583_bib51","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/S2213-2600(20)30600-7","article-title":"Assessing the importance of interleukin-6 in COVID-19","volume":"9","author":"Chen","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.heliyon.2023.e23583_bib52","doi-asserted-by":"crossref","unstructured":"Islam MM, Islam S, Ahmed R, et al., Reduced IFN-\u03b3 levels along with changes in hematologic and immunologic parameters are key to COVID-19 severity in Bangladeshi patients. Exp. Hematol..118:53-64.e51.https:\/\/10.1016\/j.exphem.2022.11.006..","DOI":"10.1016\/j.exphem.2022.11.006"},{"key":"10.1016\/j.heliyon.2023.e23583_bib53","doi-asserted-by":"crossref","unstructured":"Cremoni M, Allouche J, Gra\u00e7a D, et al., Low baseline IFN-\u03b3 response could predict hospitalization in COVID-19 patients. Front. Immunol..13:953502. https:\/\/10.3389\/fimmu.2022.953502..","DOI":"10.3389\/fimmu.2022.953502"},{"key":"10.1016\/j.heliyon.2023.e23583_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.chaos.2020.110230","article-title":"Fuzzy clustering method to compare the spread rate of Covid-19 in the high risks countries","volume":"140","author":"Mahmoudi","year":"2020","journal-title":"Chaos, Solit. Fractals"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023107912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023107912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:23:39Z","timestamp":1790655819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023107912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2405844023107912"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23583","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The immune inflammation factors associated with disease severity and poor prognosis in patients with COVID-19: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23583","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e23583"}}